Charles River Laboratories: partnership with SAMDI Tech
Charles River Laboratories has expanded its strategic partnership with SAMDI Tech. Established in 2018, the partnership gives SAMDI clients access to Charles River’s lead-like compounds for high-throughput screening; under the expanded agreement, Charles River is the exclusive partner for promotion of SAMDI technology.
“Our collaboration with SAMDI Tech is another step that we’re taking toward accelerating drug discovery and development,” said Wilbert Frieling, corporate senior vice president of global discovery services with Charles River. “By generating quality data faster during hit identification, we can help our clients make critical go/no go decisions earlier in the process, to advance their programs.”